Financials Fortrea Holdings Inc.

Equities

FTRE

US34965K1079

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
24.7 USD -0.52% Intraday chart for Fortrea Holdings Inc. -10.54% -29.23%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 3,099 2,219 - -
Enterprise Value (EV) 1 4,583 3,793 3,660 3,511
P/E ratio -873 x -23.6 x 40.8 x 19 x
Yield - - - -
Capitalization / Revenue 1 x 0.79 x 0.76 x 0.72 x
EV / Revenue 1.47 x 1.35 x 1.25 x 1.14 x
EV / EBITDA 17.1 x 16 x 10.6 x 9.01 x
EV / FCF 36.1 x 49.3 x 22 x 15.9 x
FCF Yield 2.77% 2.03% 4.55% 6.3%
Price to Book 1.78 x 1.27 x 1.15 x 1.05 x
Nbr of stocks (in thousands) 88,800 89,374 - -
Reference price 2 34.90 24.70 24.70 24.70
Announcement Date 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 3,109 2,801 2,927 3,092
EBITDA 1 - 267.3 236.8 346.8 389.5
EBIT 1 - 170.9 185.6 313.9 350.3
Operating Margin - 5.5% 6.62% 10.72% 11.33%
Earnings before Tax (EBT) 1 237 1.1 -174 -42.53 45.08
Net income 1 192.9 -3.4 -122.6 42.22 76.7
Net margin - -0.11% -4.38% 1.44% 2.48%
EPS 2 - -0.0400 -1.045 0.6050 1.297
Free Cash Flow 1 - 127.1 76.93 166.5 221.2
FCF margin - 4.09% 2.75% 5.69% 7.15%
FCF Conversion (EBITDA) - 47.55% 32.49% 48% 56.79%
FCF Conversion (Net income) - - - 394.24% 288.4%
Dividend per Share 2 - - - - -
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 793 776.4 775.4 662.1 688.4 715.3 732.4 703.8 723.4
EBITDA 1 72.5 70.5 67.2 29.5 51.4 70.16 86.72 62.71 81.54
EBIT 1 63 45.9 43.3 7.6 37.83 55.23 78.66 54.13 81.41
Operating Margin 7.94% 5.91% 5.58% 1.15% 5.5% 7.72% 10.74% 7.69% 11.25%
Earnings before Tax (EBT) - - -41 -77.5 - - - - -
Net income 1 28.3 -13.1 -36 -102.8 -34.92 -12.33 -4.827 -11.85 4.4
Net margin 3.57% -1.69% -4.64% -15.53% -5.07% -1.72% -0.66% -1.68% 0.61%
EPS 2 0.3200 -0.1500 -0.4100 -1.150 -0.2533 0.0100 0.1200 -0.0300 0.0950
Dividend per Share 2 - - - - - - - - -
Announcement Date 8/14/23 11/13/23 3/11/24 5/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 1,483 1,574 1,441 1,292
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 5.55 x 6.647 x 4.155 x 3.318 x
Free Cash Flow 1 - 127 76.9 166 221
ROE (net income / shareholders' equity) - 4.9% 3.86% 7.71% 7.99%
ROA (Net income/ Total Assets) - 2.88% 0.9% 2.11% 3.52%
Assets 1 - -118 -13,673 2,001 2,178
Book Value Per Share 2 - 19.60 19.50 21.40 23.50
Cash Flow per Share 2 - 1.970 0.2200 2.430 2.230
Capex 1 - 40.3 51.9 46.2 56.9
Capex / Sales - 1.3% 1.85% 1.58% 1.84%
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
24.83 USD
Average target price
31.8 USD
Spread / Average Target
+28.07%
Consensus
  1. Stock Market
  2. Equities
  3. FTRE Stock
  4. Financials Fortrea Holdings Inc.